79.99 USD
-10.45 (-11.55%)
80 USD
+0.01 (+0.01%)
ChartMill assigns a Buy % Consensus number of 80% to SPRB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 213.69. This target is 167.15% above the current price.
SPRB was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SPRB.
In the previous month the buy percentage consensus was at a similar level.
SPRB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-11-11 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-28 | JMP Securities | Upgrade | Market Perform -> Market Outperform |
| 2025-10-21 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-04-16 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-12 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2024-12-11 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-12-11 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-12-11 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-13 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-06-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-14 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-03-14 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-03-14 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-03-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-03-14 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-03-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-21 | Guggenheim | Initiate | Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2023-08-18 | Oppenheimer | Maintains | Outperform -> Outperform |
SPRUCE BIOSCIENCES INC / SPRB FAQ
What do analysts expect the price target to be for SPRUCE BIOSCIENCES INC (SPRB)?
8 analysts have analysed SPRB and the average price target is 213.69 USD. This implies a price increase of 167.15% is expected in the next year compared to the current price of 79.99.
What is the consensus rating for SPRB stock?
The consensus rating for SPRUCE BIOSCIENCES INC (SPRB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.